Miss Sengal Nadarajah

Professional statement

Miss Sengal Nadarajah is a consultant ophthalmologist with more than 20 years' experience. She has private practices at East Surrey Hospital and at Panacea Medical Centre in Worthing, and has a special interest in cataract surgery and medical retina, including age-related macular degeneration, diabetic eye disease, retinal vascular disease, and inflammatory eye disease. 

Following completion of her MBBS from Mangalore University, India, Miss Nadarajah specialised in ophthalmology and became a consultant at Selayang Hospital in Kuala Lumpur, a tertiary centre for retinal diseases in Malaysia. She moved to the UK in 2004, where she trained and worked as a vitreoretinal surgeon. As her interest in retinal diseases continued to grow, she pursued a medical retina fellowship at Moorfields Eye Hospital, London before working as a locum consultant at Moorfields Eye Hospital in 2016. Subsequent to her appointment as a consultant Surrey and Sussex Healthcare Trust in 2017, she was selected to the the trust's lead clinician for ophthalmology and is proud to have assisted the trust in achieving CQC overall outstanding rating over the last few years.

Drawing on her significant experience, Miss Nadarajah prides herself in providing the highest level of care, advice, and treatment for her patients. Her involvement in research projects both nationally and internationally has ensured she is at the forefront of new treatments for her patients. 

Miss Nadarajah's interest in service development led her to complete the postgraduate certificate in clinical leadership in 2013, and the Mary Seacole Leadership programme in 2015. She prides herself in developing services, including setting up one-stop retinal clinics in Western Sussex Hospitals NHS Foundation Trust in 2013, working in partnership with community optometrists for post cataract surgery review in Moorfields Croydon in 2016, and developing virtual clinics in Surrey and Sussex Healthcare Trust. She continues to develop ophthalmic services by optimising and directing technology to widen the accessibility of treatments.